Use this URL to cite or link to this record in EThOS:
Title: An investigation into the importance of T2 relaxation and echo time choice for accurate metabolite biomarker quantification
Author: Carlin, Dominic Alexander
ISNI:       0000 0004 6057 3142
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2017
Availability of Full Text:
Access from EThOS:
Access from Institution:
Metabolite concentrations are fundamental biomarkers of disease. With increasing interest in personalised medicine, this work assessed the accuracy of non-invasive metabolite quantification with magnetic resonance spectroscopy (MRS) using a combination of simulations, phantom and in vivo data. No optimal echo time (TE) was found for measuring a range of key metabolites with quantification accuracy generally influenced more by data quality than TE choice. The T2 relaxation times of water and metabolites with MRS dominated by a singlet could be estimated using 2 TEs and were found to be significantly different in paediatric brain tumours compared with normal brain, varying between tumour types. The T2 relaxation times of paediatric brain tumours were significantly shorter at 3T compared with 1.5T. Metabolite concentrations for individual patients were most affected by changes in the T2 relaxation time of water which is quick to measure. A clinical JPRESS protocol was developed which aids assignment of overlapping metabolites using changes of MRS with TE. Overall, measurement of MRS with a short TE reduces inaccuracies associated with variability in metabolite T2 and does not tend to lead to worse quantification of overlapping resonances. Further improvements in concentration accuracy can be obtained by measuring case-specific water T2.
Supervisor: Not available Sponsor: Birmingham Children's Hospital Research Foundation ; National Institute for Health Research
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: RB Pathology ; RC0254 Neoplasms. Tumors. Oncology (including Cancer) ; RJ Pediatrics